Emcure Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE168P01015
  • NSEID: EMCURE
  • BSEID: 544210
INR
1,397.75
-6.5 (-0.46%)
BSENSE

Dec 05

BSE+NSE Vol: 37.71 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
189.48
181.15
180.85
180.85
180.85
180.85
Share Warrants & Outstandings
Total Reserve
4,244.84
2,756.63
2,305.42
1,790.78
2,080.45
1,704.23
Shareholder's Funds
4,446.19
2,952.28
2,501.13
1,987.55
2,273.02
1,911.95
Minority Interest
195.37
169.48
0.00
0.00
0.00
0.00
Long-Term Borrowings
255.11
766.60
744.13
717.28
703.97
909.04
Secured Loans
251.58
761.36
737.23
708.74
707.32
897.10
Unsecured Loans
3.53
5.24
6.90
8.54
-3.35
11.94
Deferred Tax Assets / Liabilities
9.04
40.63
-60.23
-73.47
-108.41
-156.76
Other Long Term Liabilities
565.35
526.59
180.98
182.5
221.42
444.05
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
47.58
43.32
39.66
42.10
65.93
58.50
Total Non-Current Liabilities
811.91
1,377.13
904.55
868.42
882.91
899.09
Current Liabilities
Trade Payables
1,479.58
1,309.37
1,086.11
1,125.19
972.19
740.66
Other Current Liabilities
592.41
534.65
442.19
429.43
1,033.55
769.01
Short Term Borrowings
541.77
1,320.72
1,450.80
1,366.35
1,252.67
1,271.17
Short Term Provisions
54.51
45.73
40.09
43.86
149.76
138.99
Total Current Liabilities
2,668.27
3,210.47
3,019.19
2,964.83
3,408.18
2,919.84
Total Liabilities
8,121.73
7,709.37
6,573.40
5,947.39
6,659.11
5,803.29
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
5,088.43
4,735.84
3,595.89
3,266.59
3,249.37
3,284.68
Less: Accumulated Depreciation
2,241.16
1,927.59
1,655.59
1,427.65
1,061.43
1,140.91
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
2,847.27
2,808.26
1,940.30
1,838.93
2,187.93
2,143.77
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
124.06
132.34
403.53
309.80
221.59
331.94
Intangible assets under development
53.34
26.77
7.88
10.10
80.03
153.03
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
19.34
18.42
25.00
25.00
0.00
0.00
Long Term Loans & Advances
160.75
143.62
114.30
111.65
50.14
217.81
Other Non Current Assets
11.65
3.75
39.89
22.43
401.95
15.52
Total Non-Current Assets
3,565.87
3,449.45
2,737.49
2,523.29
2,941.66
3,100.21
Current Assets Loans & Advances
Current Investments
76.04
299.65
0.00
0.00
0.00
0.00
Inventories
1,931.81
1,525.10
1,383.03
1,449.41
1,514.43
1,173.15
Sundry Debtors
2,002.24
1,858.81
1,648.30
1,308.51
1,475.36
1,145.21
Cash and Bank
165.30
232.41
458.25
313.30
523.54
163.84
Other Current Assets
85.81
83.74
62.95
47.95
143.97
33.87
Short Term Loans and Advances
294.66
260.21
283.38
304.94
60.15
187.01
Total Current Assets
4,555.86
4,259.91
3,835.91
3,424.10
3,717.45
2,703.08
Net Current Assets (Including Current Investments)
1,887.59
1,049.44
816.72
459.27
309.27
-216.76
Total Current Assets Excluding Current Investments
4,479.82
3,960.26
3,835.91
3,424.10
3,717.45
2,703.08
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
8,121.73
7,709.37
6,573.40
5,947.39
6,659.11
5,803.29
Contingent Liabilities
393.94
285.51
96.95
12.07
0.00
13.95
Total Debt
0.00
2,087.31
2,194.93
2,083.63
1,581.95
1,468.73
Book Value per share (adjusted)
234.65
162.97
138.3
109.9
125.68
105.72
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -64.95% vs -4.90% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 7.36% vs 190.97% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 1.05% vs 25.46% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 4.99% vs -26.32% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 6.95% vs 11.05% in Mar 2024

Compare Balance Sheet Results of Emcure Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
189.48
15.57
173.91
1,116.96%
Share Warrants & Outstandings
Total Reserve
4,244.84
3,249.72
995.12
30.62%
Shareholder's Funds
4,446.19
3,433.32
1,012.87
29.50%
Minority Interest
195.37
0.00
195.37
0.00%
Long-Term Borrowings
255.11
0.00
255.11
0.00%
Secured Loans
251.58
0.00
251.58
0.00%
Unsecured Loans
3.53
0.00
3.53
0.00%
Deferred Tax Assets / Liabilities
9.04
168.92
-159.88
-94.65%
Other Long Term Liabilities
565.35
8.25
557.10
6,752.73%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
47.58
22.53
25.05
111.19%
Total Non-Current Liabilities
811.91
199.71
612.20
306.54%
Current Liabilities
Trade Payables
1,479.58
410.72
1,068.86
260.24%
Other Current Liabilities
592.41
145.56
446.85
306.99%
Short Term Borrowings
541.77
13.80
527.97
3,825.87%
Short Term Provisions
54.51
62.26
-7.75
-12.45%
Total Current Liabilities
2,668.27
632.34
2,035.93
321.97%
Total Liabilities
8,121.73
4,265.36
3,856.37
90.41%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
5,088.43
2,910.24
2,178.19
74.85%
Less: Accumulated Depreciation
2,241.16
960.65
1,280.51
133.30%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2,847.27
1,949.58
897.69
46.05%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
124.06
46.70
77.36
165.65%
Intangible assets under development
53.34
16.35
36.99
226.24%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
19.34
27.98
-8.64
-30.88%
Long Term Loans & Advances
160.75
32.41
128.34
395.99%
Other Non Current Assets
11.65
250.98
-239.33
-95.36%
Total Non-Current Assets
3,565.87
2,342.62
1,223.25
52.22%
Current Assets Loans & Advances
Current Investments
76.04
317.11
-241.07
-76.02%
Inventories
1,931.81
528.96
1,402.85
265.21%
Sundry Debtors
2,002.24
815.38
1,186.86
145.56%
Cash and Bank
165.30
129.45
35.85
27.69%
Other Current Assets
85.81
29.37
56.44
192.17%
Short Term Loans and Advances
294.66
102.48
192.18
187.53%
Total Current Assets
4,555.86
1,922.74
2,633.12
136.95%
Net Current Assets (Including Current Investments)
1,887.59
1,290.40
597.19
46.28%
Total Current Assets Excluding Current Investments
4,479.82
1,605.63
2,874.19
179.01%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
8,121.73
4,265.36
3,856.37
90.41%
Contingent Liabilities
393.94
131.94
262.00
198.58%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
234.65
220.54
14.11
6.40%
Annual - Borrowings
Borrowings 731.70 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -64.95% vs -4.90% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 565.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.36% vs 190.97% in Mar 2024

Annual - Fixed Assets
Fixed Assets 2,971.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.05% vs 25.46% in Mar 2024

Annual - Investments
Investments 19.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.99% vs -26.32% in Mar 2024

Annual - Current Assets
Current Assets 4,555.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.95% vs 11.05% in Mar 2024